Accessibility Menu
 
Neurotech International logo

Neurotech International

(ASX) NTI

Current Price$0.01
Market Cap$17.13M
Since IPO (2016)-95%
5 Year-82%
1 Year-50%
1 Month+18%

Neurotech International Financials at a Glance

Market Cap

$17.13M

Revenue (TTM)

$2.41M

Net Income (TTM)

$15.64M

EPS (TTM)

$-0.00

P/E Ratio

-3.51

Dividend

$0.00

Beta (Volatility)

-0.21 (Low)

Price

$0.01

Volume

1,250,076

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

NTI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neurotech International

Industry

Healthcare Equipment and Supplies

CEO

Anthony Filippis, PhD, MBA

Headquarters

Nedlands, WA 6009, AU

NTI Financials

Key Financial Metrics (TTM)

Gross Margin

3%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

-66%

Return on Capital

-58%

Return on Assets

-57%

Earnings Yield

-28.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.13M

Shares Outstanding

1.32B

Volume

1.25M

Short Interest

0.00%

Avg. Volume

1.46M

Financials (TTM)

Gross Profit

$2.44M

Operating Income

$11.09M

EBITDA

$10.74M

Operating Cash Flow

$9.02M

Capital Expenditure

$0.00

Free Cash Flow

$9.02M

Cash & ST Invst.

$3.03M

Total Debt

$0.00

Neurotech International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$17.13M

N/A

Market Cap/Employee

$951.70K

N/A

Employees

18

N/A

Net Income

$696.50K

+4.4%

EBITDA

$5.43M

-39.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$6.34M

+41.6%

Accounts Receivable

$375.08K

+99.6%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-56.54%

N/A

Return on Invested Capital

-57.51%

N/A

Free Cash Flow

$38.33K

+95.6%

Operating Cash Flow

$38.33K

+95.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AGH.AXAlthea Group Holdings Limited
$0.02-4.76%
BTC.AXBTC Health Limited
$0.05-1.82%
CBL.AXControl Bionics Limited
$0.06+0.00%
MDR.AXMedAdvisor Limited
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.78-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.96+0.02%

Questions About NTI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.